Key Insights

Highlights

Success Rate

100% trial completion (above average)

Research Leaders

9 sponsors active, led by Bambino Gesù Hospital and Research Institute

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials

NCT06276244Completed

Trial Readiness and Endpoint Assessment in Congenital and Childhood Myotonic Dystrophy

Showing all 1 trials

Research Network

Active Sponsors

Bambino Gesù Hospital and Research Institute1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1
IRCCS Istituto delle Scienze Neurologiche di Bologna1
IRCCS Fondazione Stella Maris1
IRCCS National Neurological Institute "C. Mondino" Foundation1

Related Conditions

Cdm1

ChDM